The Skin Cancer Foundation Journal

MAY 2014

The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.

Issue link: https://skincancer.epubxp.com/i/319518

Contents of this Issue

Navigation

Page 9 of 103

RAVAGED BY THE RAYS? (P.16) DEBORAH S. SARNOFF, MD, Clinical Professor of Dermatology at NYU School of Medicine, is in private practice in Manhattan and Long Island. She is also Senior Vice President of The Skin Cancer Foundation. Dr. Sarnoff authored Beauty and the Beam: Your Complete Guide to Cosmetic Laser Surgery, and Instant Beauty: Getting Gorgeous on Your Lunch Break ( St. Martin's Press). SUNSCREEN REDUCES SKIN AGING (P.20) ADELE C. GREEN, MD, BS, PhD, MSc, is one of the world's most esteemed authorities on the epidemiology and prevention of cancer. Senior researcher at QIMR Berghofer Medical Research Institute in Queensland, Australia, she has served on many national and international research committees and currently sits on the International Commis- sion on Non-Ionising Radiation Protection. Dr. Green has published over 350 peer-reviewed research articles, most of them on cancer epidemiology. She was selected as the top woman of infuence in Australia for 2013. WHY YOU SHOULDN'T TAN (P.26) DAVID E. FISHER, MD, PhD, is Chief of the Department of Dermatology, Director of the MGH Cutaneous Biology Research Center and Director of the Melanoma Center at Massachusetts General Hospital in Boston. He is a Professor of Dermatology and of Pediatrics at Harvard Medical School. Dr. Fisher previously directed the Melanoma Program at Dana-Farber Cancer Institute. ALAN GELLER is a Senior Lecturer at the Harvard School of Public Health and the Director of Melanoma Epidemiology at Massachusetts General Hospital. He has been funded by the CDC, NIH, EPA, and AAD for his work in skin cancer screening, public and professional education, and tanning bed research. ELENA B. HAWRYLUK, MD, PhD, is a dermatologist who trained at the Harvard Combined Dermatology Program, where she was Chief Resident. She recently received a grant from the Dermatology Foundation to support her research and fellowship training to specialize in pediatric dermatology at Boston Children's Hospital. THE JOY OF WEARING SUNSCREEN (P.25) ZOE DIANA DRAELOS, MD, is a Consulting Professor of Dermatology at Duke University in Durham, NC. Past Vice- President of the American Academy of Dermatology (AAD), she is also a past member of the AAD's and the American Society for Dermatologic Surgery's Board of Directors. Dr. Draelos founded Dermatology Consulting Services in 1988 to provide education, develop formulations, and conduct clinical studies in association with industry. Author of Cosmetics in Dermatology and Hair Cosmetics, she is also Editor of Cosmeceuticals and editor-in-chief of the Journal of Cosmetic Dermatology. ...THOSE BEAUTIFULLY POLISHED NAILS? (P.30) MARAL KIBARIAN SKELSEY, MD, is Director of the Der- matologic Surgery Center of Washington, in Washington, DC. She is also Director of the Mohs Surgery Unit and Clinical Assistant Professor of Dermatology at Georgetown University. Dr. Skelsey is a member of The Skin Cancer Foundation's Amonette Circle. AFTER THE DAMAGE IS DONE (P.32) RONALD L. MOY, MD, practices dermatology, Mohs micro- graphic surgery, and cosmetic surgery in Beverly Hills, CA. He has been Editor-in-Chief of the Journal of Dermatologic Surgery, President of the American Society for Dermatologic Surgery, and is a Past President of the American Academy of Dermatology. He is currently on the Editorial Board of Archives of Facial Plastic Surgery and Aesthetic Surgery and is Senior Vice President for the Skin Cancer Foundation. THAT'S NOT OUR DISEASE (P.43) ADELLE T. QUINTANA, MD, is a dermatologist and Mohs surgeon specializing in cosmetic procedures, skin cancer, and other diseases of the skin. An attending physician at NYU Medical Center, where she also instructs dermatology residents, she is a member of many local, national and international medical societies, including the Robins Fund for the Advancement of Mohs Surgery. She is in private practice in New York City. SKIN CANCER IN THE REAGAN WHITE HOUSE (P.48) C. WILLIAM HANKE, MD, is Senior Vice President of The Skin Cancer Foundation. He graduated from the University of Iowa College Of Medicine and has practiced Mohs surgery in Indianapolis for many years. He is Past President of the American Society for Dermatologic Surgery, the International Society of Dermatologic Surgery, the American College of Mohs Surgery, and the American Academy of Dermatology. WHY IS MELANOMA DEADLIER...? (P.55) SUSAN M. SWETTER, MD, is Professor of Dermatology and Director of the Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, CA. CHRISTINA A. CLARKE, PhD, MPH, is a research scientist, Cancer Prevention Institute of California, and Consulting Associate Professor, Dept. of Health Research & Policy, Stanford University School of Medicine. THERESA H. M. KEEGAN, PhD, is a research scientist at the Cancer Prevention Institute of California, and Consulting Assistant Professor, Dept. of Health Research & Policy, Stanford University School of Medicine. SKIN CANCER TREATMENT: THE OPTIONS (P.60) EUGENE BAIN III, MD, is currently completing his fellowship in Mohs micrographic surgery and procedural dermatology at New York University's Ronald O. Perelman Department of Dermatology under the instruction of John Carucci, MD, and Elizabeth Hale, MD. He will be opening Bain Dermatology, P.A. in Raleigh, NC, in August of this year. JOHN A. CARUCCI, MD, PhD, is the Chief of Mohs Micro- graphic and Dermatologic Surgery and an Associate Profes- sor in the Ronald O. Perelman Department of Dermatology at NYU-Langone Medical Center. He is the Program Director for the Mohs Surgery and Cutaneous Oncology Fellowship at NYU. Dr. Carucci is a member of the Board of Directors of the American College of Mohs Micrographic Surgery. He has served on the Board of Directors and as Chairman of the Research Committee for the International Transplant Skin Cancer Collaborative, and as Chairman of the American Academy of Dermatology's Skin Cancer Committee. ELIZABETH K. HALE, MD, is Clinical Associate Professor of Dermatology at New York University School of Medicine. She specializes in Mohs micrographic surgery, dermato- logic surgery, cosmetic dermatology and laser surgery. Dr. Hale currently practices at CompleteSkinMD and teaches advanced dermatologic surgery to New York University dermatology residents. She lectures extensively on the prevention and treatment of skin cancer. Dr. Hale is a Vice President of The Skin Cancer Foundation and Medical Editor of The Skin Cancer Foundation Journal. THE SKIN CANCER ENIGMA (P.64) HEATHER ROGERS, MD, is a dermatologist and Mohs micrographic surgeon who specializes in the prevention and treatment of sun damage and skin cancer. A Clinical Professor at the University of Washington School of Medicine, she reviews manuscripts for the Journal of Dermatologic Surgery, and serves as a member of the American Academy of Dermatology media expert team. Dr. Rogers is also Co-director of the Madison Skin and Laser Center in Seattle, WA. UNSTOPPABLE NO MORE (P.68) JASON J. LUKE, MD, is Instructor in Medicine at Harvard Medical School and the Melanoma Disease Center of Dana-Farber Cancer Institute in Boston. His clinical research focuses on the development of new medicines for cancer and the interaction between targeted therapy and the immune system in patients with melanoma. F. STEPHEN HODI, MD, is Associate Professor of Medicine at Harvard Medical School and Leader of the Melanoma Disease Center of Dana-Farber Cancer Institute. His laboratory and clinical research focuses on utilizing the immune system to treat patients with melanoma and other cancers. PATRICK A. OTT, MD, PhD, is Assistant Professor of Medicine at Harvard Medical School and Clinical Director of the Melanoma Disease Center of Dana-Farber Cancer Institute. His clinical research focuses on the development of new immunotherapies to treat patients with melanoma and advanced cancer. BURNING FOR A TAN (P.71) MUTHU SIVARAMAKRISHNAN, MD, is a specialist registrar in Dermatology at Ninewells Hospital and Medical School in Dundee, UK. He graduated medical school in India and underwent higher medical training in the UK. His special interests include dermatosurgery, lasers in dermatology, and phototherapy. COLIN FLEMING, MRCP, is a Consultant Dermatologist and Clinical Director of Specialist Services at Ninewells Hospital and Medical School in Dundee, UK. He is currently the President of the British Society for Dermatological Surgery. RESCUE FOR REDHEADS (P.74) PROFESSOR DAVID C. WHITEMAN, MBBS, PhD, is Group Leader of the Cancer Control Group at QIMR Berghofer Medical Research Institute in Brisbane, Queensland, Australia. ELKE HACKER, PhD, is a postdoctoral research fellow at QIMR Berghofer Medical Research Institute and in the School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia. Contributors S K I N C A N C E R F O U N D A T I O N J O U R N A L 8

Articles in this issue

view archives of The Skin Cancer Foundation Journal - MAY 2014